Home > Rheumatology > EULAR 2022 > Global safety report data show more VTE events on JAK inhibition in RA

Global safety report data show more VTE events on JAK inhibition in RA

Presented By
Prof. Adeline Ruyssen-Witrand, University Hospital of Toulouse III Paul Sabatier, France
Conference
EULAR 2022
A register study explored the worldwide collected data on major cardiovascular events (MACEs) and venous thromboembolism (VTE) associated with JAK inhibitors compared to anti-TNF agents in rheumatoid arthritis (RA). Overall, VTE events were markedly increased with JAK inhibitors, whereas regarding MACEs a higher frequency was only seen in the physician-reported cases. To further elucidate recently emerged concerns about cardiovascula...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on